Middle East & North Africa (MENA) Laws (Overview) — THC‑Free CBD 2025

This page offers a conservative, high‑level orientation to rules across MENA that may affect CBD products marketed as “THC‑free.” It is not legal advice. Policies and enforcement can be strict; verify specifics with competent national authorities (interior, health, customs) and current laws. Reviewed through early 2025.

Regional snapshot

Strict enforcement remains common: Many MENA jurisdictions treat cannabinoids as controlled substances. Do not assume consumer CBD is permitted—ND‑THC COAs do not create legal pathways.
Country variation: Rules differ widely (criminal, administrative, or tightly controlled medical channels). Regulations and enforcement priorities can change without broad notice.
Retail visibility is not reliability: Online availability or tourist‑area storefronts are not proof of legality.

What “THC‑free” means (lab vs. law)

“THC‑free” is a testing outcome, not a legal category. On a Certificate of Analysis (COA), delta‑9 THC (and often THCA) may be reported as Not Detected (ND) at the laboratory’s Limit of Quantitation (LOQ). Laws may still restrict CBD itself or all cannabinoids, regardless of ND‑THC results. See: How to Read COAs and LOQ vs LOD.

Import, retail, and documentation

Import permits: Where import is possible, permits or product registrations are typically required. Personal import allowances may be very limited or absent.
Medical channels: Some countries reference narrow, physician‑supervised pathways for specific products; these are not general consumer authorizations.
Documentation: Batch‑matched COAs, ingredient lists, and manufacturer attestations may be requested but do not guarantee acceptance at borders or by inspectors.
Claims and labels: Disease/medical claims and “zero THC” assertions can invite scrutiny. Prefer precise, non‑misleading labeling.

Travel and transit

High risk: Carrying CBD—even “THC‑free”—can result in seizure or penalties at borders and internal checkpoints.
Transit hubs: Major airports and carriers may involve screening under strict national laws. Avoid vapes and unlabeled items.
If travel is essential, review International Travel Guidelines and carrier/consulate guidance; consider not carrying CBD.

Country highlights (examples to verify)

Examples below are illustrative, not exhaustive. Always confirm with current, official sources before purchase, import, or carriage.

United Arab Emirates (UAE): Historically strict enforcement toward cannabinoids; travelers should avoid carrying CBD. See our UAE overview.
Saudi Arabia, Qatar, Kuwait, Bahrain: Generally strict narcotics frameworks; presume CBD is prohibited absent explicit official guidance.
Egypt, Jordan, Morocco, Tunisia: Laws and enforcement vary; do not assume consumer CBD retail is permitted. Confirm with relevant ministries and customs.
Israel: Policy landscape differs from nearby jurisdictions and is evolving; verify current status directly with government sources before any action.

How to verify quickly

Identify the competent authorities (interior, health, customs, drug control) on official government sites.
Confirm definitions: whether all cannabinoids are controlled, if hemp extracts are distinguished, and whether any medical‑only pathways exist.
Ask about import (personal vs. commercial), retail permissions, and documentation (registrations, permits, COAs).
Document answers (screenshots, references, dates) and assume policies can change.

FAQ

Is a “THC‑free” COA enough to enter a MENA country with CBD?
No. ND‑THC at a lab’s LOQ does not create a legal right to import or possess CBD. Verify the law and, if applicable, obtain permits in advance.

Can I buy CBD locally if I see it for sale?
Retail availability is not proof of legality. Enforcement may be inconsistent. Purchasing can still carry risk.

Should I travel with CBD through MENA hubs?
Generally avoid. If you must, review official guidance, carry original packaging and batch COAs, and be prepared for seizure or denial.